Cargando…

When to perform curettage after uterine artery embolization for cesarean scar pregnancy: a clinical study

BACKGROUND: Prophylactic uterine artery embolization (UAE) combined with subsequent curettage is suggested as an effective and minimally invasive treatment strategy for cesarean scar pregnancy (CSP) with a high bleeding risk. However, the timing of curettage after UAE remains to be studied. Thus, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qiao, Peng, Hongling, Zhao, Xia, Qi, Xiaorong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108320/
https://www.ncbi.nlm.nih.gov/pubmed/33971838
http://dx.doi.org/10.1186/s12884-021-03846-x
_version_ 1783690108016263168
author Wang, Qiao
Peng, Hongling
Zhao, Xia
Qi, Xiaorong
author_facet Wang, Qiao
Peng, Hongling
Zhao, Xia
Qi, Xiaorong
author_sort Wang, Qiao
collection PubMed
description BACKGROUND: Prophylactic uterine artery embolization (UAE) combined with subsequent curettage is suggested as an effective and minimally invasive treatment strategy for cesarean scar pregnancy (CSP) with a high bleeding risk. However, the timing of curettage after UAE remains to be studied. Thus, we aimed to identify the optimal time interval to perform curettage after UAE in patients with CSP. METHODS: We conducted a retrospective cohort study in a large medical center for women and children in Southwest China. CSP patients treated by UAE combined with subsequent curettage were included and grouped by the treatment time interval between these two procedures. The clinical outcomes among arms were compared by univariate and multivariable analysis. RESULTS: Our study included 314 CSP patients who received this combination treatment in our department from January 2014 to December 2019. The median time interval between UAE and curettage was 48 h, with a range of 12-168 h among all participants. Thirty-two patients (10.2%) experienced intraoperative hemorrhage (blood loss ≥200 mL). Intrauterine balloon tamponade was used in 17 cases (5.4%). In 14 cases (4.5%), the procedure was converted to laparoscopy (or laparotomy). In the cohort study, patients with longer treatment intervals had more intraoperative blood loss and a higher incidence of complications than those with shorter intervals (P < 0.05). The rates of intraoperative bleeding were 5.0% for patients who received curettage within 24 h after UAE (Arm 1) and 19.4% for those who had a treatment interval longer than 72 h (Arm 4). In the multivariable logistic regression model of bleeding, a treatment interval > 72 h had an adjusted odds ratio of 3.37 (95% confidence interval: 1.40-8.09). CONCLUSION: We suggest that curettage not be delayed longer than 72 h after UAE in this combined treatment of CSP.
format Online
Article
Text
id pubmed-8108320
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81083202021-05-11 When to perform curettage after uterine artery embolization for cesarean scar pregnancy: a clinical study Wang, Qiao Peng, Hongling Zhao, Xia Qi, Xiaorong BMC Pregnancy Childbirth Research BACKGROUND: Prophylactic uterine artery embolization (UAE) combined with subsequent curettage is suggested as an effective and minimally invasive treatment strategy for cesarean scar pregnancy (CSP) with a high bleeding risk. However, the timing of curettage after UAE remains to be studied. Thus, we aimed to identify the optimal time interval to perform curettage after UAE in patients with CSP. METHODS: We conducted a retrospective cohort study in a large medical center for women and children in Southwest China. CSP patients treated by UAE combined with subsequent curettage were included and grouped by the treatment time interval between these two procedures. The clinical outcomes among arms were compared by univariate and multivariable analysis. RESULTS: Our study included 314 CSP patients who received this combination treatment in our department from January 2014 to December 2019. The median time interval between UAE and curettage was 48 h, with a range of 12-168 h among all participants. Thirty-two patients (10.2%) experienced intraoperative hemorrhage (blood loss ≥200 mL). Intrauterine balloon tamponade was used in 17 cases (5.4%). In 14 cases (4.5%), the procedure was converted to laparoscopy (or laparotomy). In the cohort study, patients with longer treatment intervals had more intraoperative blood loss and a higher incidence of complications than those with shorter intervals (P < 0.05). The rates of intraoperative bleeding were 5.0% for patients who received curettage within 24 h after UAE (Arm 1) and 19.4% for those who had a treatment interval longer than 72 h (Arm 4). In the multivariable logistic regression model of bleeding, a treatment interval > 72 h had an adjusted odds ratio of 3.37 (95% confidence interval: 1.40-8.09). CONCLUSION: We suggest that curettage not be delayed longer than 72 h after UAE in this combined treatment of CSP. BioMed Central 2021-05-10 /pmc/articles/PMC8108320/ /pubmed/33971838 http://dx.doi.org/10.1186/s12884-021-03846-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wang, Qiao
Peng, Hongling
Zhao, Xia
Qi, Xiaorong
When to perform curettage after uterine artery embolization for cesarean scar pregnancy: a clinical study
title When to perform curettage after uterine artery embolization for cesarean scar pregnancy: a clinical study
title_full When to perform curettage after uterine artery embolization for cesarean scar pregnancy: a clinical study
title_fullStr When to perform curettage after uterine artery embolization for cesarean scar pregnancy: a clinical study
title_full_unstemmed When to perform curettage after uterine artery embolization for cesarean scar pregnancy: a clinical study
title_short When to perform curettage after uterine artery embolization for cesarean scar pregnancy: a clinical study
title_sort when to perform curettage after uterine artery embolization for cesarean scar pregnancy: a clinical study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108320/
https://www.ncbi.nlm.nih.gov/pubmed/33971838
http://dx.doi.org/10.1186/s12884-021-03846-x
work_keys_str_mv AT wangqiao whentoperformcurettageafteruterinearteryembolizationforcesareanscarpregnancyaclinicalstudy
AT penghongling whentoperformcurettageafteruterinearteryembolizationforcesareanscarpregnancyaclinicalstudy
AT zhaoxia whentoperformcurettageafteruterinearteryembolizationforcesareanscarpregnancyaclinicalstudy
AT qixiaorong whentoperformcurettageafteruterinearteryembolizationforcesareanscarpregnancyaclinicalstudy